✦ LIBER ✦

Behçet’s Ileocolitis: Successful Treatment With Tumor Necrosis Factor–Alpha Antibody (Infliximab) Therapy

✍ Scribed by MichaelT. Kram; LouisD. May; Stephen Goodman; Sharon Molinas

Publisher: Springer
Year: 2003
Tongue: English
Weight: 550 KB
Volume: 46
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-004-6506-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of active ankylosin

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

✍ Jan Brandt; Hildrun Haibel; Daniel Cornely; Werner Golder; José Gonzalez; Jaquel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Lack of association of tumor necrosis fa

Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet’s disease

✍ Aşkın Ateş; Gülay Kinikli; Nurşen Düzgün; Murat Duman 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 244 KB

Anti-tumor necrosis factor-alpha antibod

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis

✍ Yasunori Kageyama; Eiji Torikai; Akira Nagano 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 274 KB

Pneumocystis jirovecipneumonia in a pati

Pneumocystis jirovecipneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor α neutralizing antibody

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Kanako Ito; Yukinori Koga; Izum 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 350 KB

Stabilization of Lung Function and Clini

Stabilization of Lung Function and Clinical Symptoms in a Patient with Cystic Fibrosis (CF) After Institution of Infliximab: A Monoclonal Antibody that Binds Tumor Necrosis Factor alpha

✍ Brian Casserly; Walter Donat 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB

Assessment of antibodies to double-stran

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

✍ P. J. Charles; R. J. T. Smeenk; J. De Jong; M. Feldmann; R. N. Maini 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra